Paul Vigano Sells 1 Million Shares of Aveanna Healthcare

Paul Vigano, an insider at Aveanna Healthcare Holdings Inc., sold 1 million shares of the company on June 24, 2026. The shares were sold at an average price of $8 each, amounting to a total transaction value of $8 million. This transaction was not part of a pre-arranged trading plan.

Insider Buying and Selling at Aveanna Healthcare Holdings Inc.

On the same day, J.H. Whitney Equity Partners VII, LLC sold 919,389 shares at the same price. Earlier in the month, on June 3, Paul Vigano sold an additional 7 million shares at $6.24 each. Other insiders, including Robert Williams Jr., also sold significant shares in early June.

Other Institutional Activity in Aveanna Healthcare

Several institutional investors have adjusted their positions in Aveanna Healthcare. Nut Tree Capital Management, LP increased its holdings by 550,000 shares, reaching a total of 12,922,649 shares valued at approximately $83.2 million, a 4.4% increase. In contrast, BlackRock, Inc. reduced its stake by 656,532 shares, leaving it with 5,500,912 shares worth about $35.4 million, marking a 10.7% decrease. Summit Partners L.P. also trimmed its holdings by 2.1 million shares, a 27.8% decrease, resulting in 5,451,422 shares valued at $35.1 million. Meanwhile, Vanguard Capital Management LLC opened a new position with 3,974,819 shares valued at $25.6 million.

Aveanna Healthcare Holdings Inc. Stock Down 35.0%

Shares of NasdaqGS:AVAH traded near $8.48 on Saturday. Aveanna Healthcare has a market capitalization of about $1.89 billion and a P/E ratio of 7.16. The stock has experienced a 52-week low of $3.73 and a high of $10.32. Its 50-day moving average is $7.10, and the 200-day moving average is $7.98. The company maintains a current ratio of 1.47 and a quick ratio of 1.37, with a debt-to-equity ratio of 623.92.

Analysts Set New Price Targets

On May 18, 2026, Barclays maintained its 'buy' rating on Aveanna with a price target of $9. Stephens & Co. upgraded the stock to a 'buy' on May 15, setting a target of $11. RBC Capital maintained its 'hold' rating with a $10 target on the same day. The consensus among analysts is a 'buy' recommendation, with a mean price target of $10.05, based on 10 analyst opinions.

About Aveanna Healthcare

Aveanna Healthcare Holdings Inc. is a healthcare company based in Atlanta, Georgia. It provides pediatric and adult healthcare services across the United States. The company operates through three segments: Private Duty Services, Home Health & Hospice, and Medical Solutions. Aveanna's services allow patients to receive care at home, avoiding more expensive facilities like hospitals. Led by CEO Jeffrey S. Shaner, the company employs about 3,500 people.

Bottom Line

Paul Vigano's recent sale of 1 million shares of Aveanna Healthcare highlights ongoing insider activity within the company. Aveanna's stock, trading near $8.48, reflects a strong market presence with a substantial market cap. Analysts maintain a positive outlook, with several firms recommending it as a 'buy'. As always, note that insider transactions are reported after the fact and may not reflect current holdings.